REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,380,292 | +10.1% | 2,072,732 | +6.4% | 0.01% | +16.7% |
| Q2 2023 | $52,121,322 | +38.8% | 1,948,460 | +12.4% | 0.01% | +20.0% |
| Q1 2023 | $37,560,123 | +108883.6% | 1,734,077 | +19.9% | 0.01% | 0.0% |
| Q4 2022 | $34,464 | -99.9% | 1,446,856 | +5.0% | 0.01% | +25.0% |
| Q3 2022 | $27,185,000 | +19.7% | 1,378,552 | +18.3% | 0.00% | +33.3% |
| Q2 2022 | $22,720,000 | -20.5% | 1,165,758 | +4.0% | 0.00% | -25.0% |
| Q1 2022 | $28,595,000 | +3.0% | 1,120,941 | +1.6% | 0.00% | +33.3% |
| Q4 2021 | $27,775,000 | -6.6% | 1,103,497 | +2.1% | 0.00% | -25.0% |
| Q3 2021 | $29,736,000 | -0.8% | 1,080,939 | +14.5% | 0.00% | 0.0% |
| Q2 2021 | $29,964,000 | -16.1% | 944,058 | +21.3% | 0.00% | -20.0% |
| Q1 2021 | $35,722,000 | +40.5% | 778,600 | +21.2% | 0.01% | +25.0% |
| Q4 2020 | $25,431,000 | +16.7% | 642,365 | +2.6% | 0.00% | 0.0% |
| Q3 2020 | $21,788,000 | +170.5% | 626,100 | +145.4% | 0.00% | +100.0% |
| Q2 2020 | $8,055,000 | +204.2% | 255,160 | +111.1% | 0.00% | +100.0% |
| Q1 2020 | $2,648,000 | – | 120,878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |